These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 33452689)

  • 1. EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.
    Sokolowska M; Eiwegger T; Ollert M; Torres MJ; Barber D; Del Giacco S; Jutel M; Nadeau KC; Palomares O; Rabin RL; Riggioni C; Vieths S; Agache I; Shamji MH
    Allergy; 2021 Jun; 76(6):1629-1639. PubMed ID: 33452689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.
    Klimek L; Jutel M; Akdis CA; Bousquet J; Akdis M; Torres MJ; Agache I; Canonica GW; Del Giacco S; O'Mahony L; Shamji MH; Schwarze J; Untersmayr E; Ring J; Bedbrook A; Worm M; Zuberbier T; Knol E; Hoffmann-Sommergruber K; Chivato T
    Allergy; 2021 Jun; 76(6):1624-1628. PubMed ID: 33378789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction - own observations.
    Wentrys Ł; Stopyra L
    Przegl Epidemiol; 2021; 75(3):315-325. PubMed ID: 35170287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions.
    Haq HN; Khan H; Chaudhry H; Nimmala S; Demidovich J; Papudesi BN; Potluri SD
    J Natl Med Assoc; 2022 Dec; 114(6):601-612. PubMed ID: 36511275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
    Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
    Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.
    Banerji A; Wickner PG; Saff R; Stone CA; Robinson LB; Long AA; Wolfson AR; Williams P; Khan DA; Phillips E; Blumenthal KG
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1423-1437. PubMed ID: 33388478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights.
    Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ
    Interdiscip Sci; 2021 Jun; 13(2):344-347. PubMed ID: 34021862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).
    Novembre E; Tosca M; Caffarelli C; Calvani M; Cardinale F; Castagnoli R; Chiappini E; Cravidi C; Del Giudice MM; Duse M; Licari A; Manti S; Martelli A; Ricci G; Pingitore G; Marseglia GL
    Ital J Pediatr; 2022 May; 48(1):76. PubMed ID: 35578294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19.
    Halder A; Imamura H; Condon S; Boroughs K; Nilsson SC; Anderson T; Caterson ID
    Intern Med J; 2022 Jan; 52(1):121-124. PubMed ID: 35060290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
    Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT
    Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy.
    Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y
    Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines.
    Shavit R; Maoz-Segal R; Offengenden I; Yahia SH; Maayan DM; Lifshitz Y; Niznik S; Deutch M; Elbaz E; Genaim H; Iancovici-Kidon M; Agmon-Levin N
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2677-2684. PubMed ID: 35973526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA).
    Klimek L; Novak N; Hamelmann E; Werfel T; Wagenmann M; Taube C; Bauer A; Merk H; Rabe U; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Jakob T; Ankermann T; Schmidt SM; Gerstlauer M; Vogelberg C; Zuberbier T; Hartmann K; Worm M
    Allergo J Int; 2021; 30(2):51-55. PubMed ID: 33643776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    Fleming-Dutra KE; Wallace M; Moulia DL; Twentyman E; Roper LE; Hall E; Link-Gelles R; Godfrey M; Woodworth KR; Anderson TC; Rubis AB; Shanley E; Jones JM; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley M; Meyer S; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):859-868. PubMed ID: 35771731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.